USANA Health Sciences (USNA)
Makes supplements and kids wellness products across direct-selling and direct-to-consumer channels.
$14.82
vs last close+0.33 (+2.28%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Jan 2026 | Q1 FY26Apr 2026 | Q2 FY26Jul 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 213 | 221 | 228 | 213 | 200 | 214 | 250 | 236 | 214 | 226 | 250 | 223 |
| Cost of revenue | 46 | 45 | 46 | 44 | 43 | 43 | 61 | 58 | 49 | 49 | 59 | 48 |
| Gross profit | 168 | 176 | 182 | 169 | 157 | 171 | 189 | 178 | 165 | 177 | 191 | 175 |
| 150 | 152 | 157 | 151 | 142 | 163 | 173 | 161 | 164 | 160 | 177 | 195 | |
| 150 | 152 | 157 | 151 | 142 | 163 | 173 | 161 | 86 | 78 | 88 | 82 | |
| General & administrative | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 86 | 78 | 0 | 0 |
| Other expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 78 | 81 | 89 | 113 |
| Operating income | 18 | 24 | 25 | 18 | 16 | 8 | 16 | 17 | 1 | 17 | 14 | −20 |
| 3 | 2 | 2 | 2 | 3 | 2 | 1 | 2 | 1 | −13 | 2 | 1 | |
| Interest income | 3 | 3 | 3 | 3 | 3 | 3 | 1 | 1 | 1 | 0 | 0 | 1 |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income | −3 | −3 | −2 | −2 | −3 | −2 | −1 | −2 | −1 | 13 | −2 | −1 |
| Income before tax | 21 | 27 | 27 | 20 | 19 | 10 | 17 | 19 | 2 | 4 | 15 | −19 |
| Income tax expense | 9 | 10 | 11 | 10 | 8 | 6 | 7 | 8 | 8 | 6 | 9 | 9 |
| Net income from continuing operations | 11 | 17 | 17 | 10 | 11 | 4 | 9 | 10 | −7 | −2 | 7 | −28 |
| Net income | 11 | 17 | 17 | 10 | 11 | 4 | 9 | 10 | −7 | −2 | 8 | −21 |
| EPS, basic | $0.59 | $0.88 | $0.86 | $0.55 | $0.56 | $0.23 | $0.49 | $0.52 | −$0.36 | −$0.10 | $0.41 | −$1.16 |
| EPS, diluted | $0.59 | $0.87 | $0.86 | $0.54 | $0.56 | $0.23 | $0.49 | $0.52 | −$0.36 | −$0.10 | $0.41 | −$1.16 |
| Weighted average shares, basic | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 18 | 18 | 18 | 18 |
| Weighted average shares, diluted | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 18 | 18 | 18 | 18 |
| EBITDA | 26 | 32 | 32 | 26 | 24 | 16 | 27 | 29 | 11 | 15 | 25 | −19 |
| Depreciation & amortization | 5 | 5 | 5 | 6 | 6 | 6 | 10 | 10 | 10 | 10 | 10 | 0 |
| EBIT | 21 | 27 | 27 | 20 | 19 | 11 | 17 | 19 | 2 | 4 | 16 | −19 |
